Stable Cell Line Development for Antibodies and Viral Proteins | AtaGenix Case Studies

Fig 1. Antibody Monoclonal Yield Analysis. Different clones show yield differences, with top performers exceeding 3 g/L, demonstrating high productivity.

Fig 2. Stability Analysis of Antibody Clones. Expression levels remain consistent across passages, ensuring long-term stability of selected clones.

Fig 3. Mycoplasma Testing of Cell Banks (PCR Method). No contamination detected, confirming biosafety and reliability of the CHO cell banks.

MW: DL2000 Marker. +: Positive control (290 bp). -: Negative control.

Fig 4. Antibody Purity Analysis of Top1 Cell Line. High purity confirmed by SDS-PAGE, showing minimal impurities and consistent antibody quality.

Fig 5. Top1 Cell Line Antibody Affinity Detection. Binding kinetics confirm strong affinity, validating clone selection for therapeutic development.

Fig 1. QC SDS-PAGE Analysis of Different Clones. Distinct bands confirm expression of gE protein, supporting downstream vaccine-related studies.

Lane MW: Protein Marker

Need reliable cell line development for antibody or viral protein projects? AtaGenix provides custom solutions from gene design to stable cell bank validation.